Evidence mapPaperPMID 41226708Full record

ReviewInternational journal of molecular sciences2025

Polyphenolic Compounds in the Prevention and Treatment of Hypertension: A Review.

Remigiusz Olędzki

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Remigiusz OlędzkiDepartment of Biotechnology and Food Analysis, Wroclaw University of Economics and Business, Komandorska 118/120, 53-345 Wroclaw, Poland.ORCID 0000-0002-3817-8619

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, there has been a growing consumer interest in natural food raw materials and the bioactive compounds they contain. Current research findings from leading research centres on the effects of polyphenolic bioactive compounds have sparked a discussion on the use of polyphenolic compounds as natural therapeutics in the prevention of lifestyle diseases, including cardiovascular diseases such as hypertension. This paper reviews original scientific research on the potential use of polyphenolic bioactive compounds in reducing primary and secondary hypertension. The paper also describes the mechanisms by which bioactive compounds act in the process of counteracting hypertension. Based on these observations, key therapeutic and dietary recommendations for the prevention of hypertension are formulated.

Indexed as

Antihypertensive AgentsHypertensionPolyphenolsAnimalsHumansAntihypertensive AgentsPolyphenolsangiotensin-converting enzymeantioxidantshypertensionpolyphenolsRAA system

Identifiers

PMID41226708
PMCPMC12608774

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.